ES2909557T3 - Utilización de la pridopidina para el tratamiento del síndrome de Rett - Google Patents
Utilización de la pridopidina para el tratamiento del síndrome de Rett Download PDFInfo
- Publication number
- ES2909557T3 ES2909557T3 ES17851614T ES17851614T ES2909557T3 ES 2909557 T3 ES2909557 T3 ES 2909557T3 ES 17851614 T ES17851614 T ES 17851614T ES 17851614 T ES17851614 T ES 17851614T ES 2909557 T3 ES2909557 T3 ES 2909557T3
- Authority
- ES
- Spain
- Prior art keywords
- pridopidine
- subject
- composition
- administered
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662395854P | 2016-09-16 | 2016-09-16 | |
| PCT/US2017/051803 WO2018053280A1 (en) | 2016-09-16 | 2017-09-15 | Use of pridopidine for treating rett syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2909557T3 true ES2909557T3 (es) | 2022-05-09 |
Family
ID=61619744
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17851614T Active ES2909557T3 (es) | 2016-09-16 | 2017-09-15 | Utilización de la pridopidina para el tratamiento del síndrome de Rett |
| ES22150695T Active ES2986807T3 (es) | 2016-09-16 | 2017-09-15 | Pridopidina para su uso en el tratamiento del síndrome de Rett |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES22150695T Active ES2986807T3 (es) | 2016-09-16 | 2017-09-15 | Pridopidina para su uso en el tratamiento del síndrome de Rett |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP3512506B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6977029B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109982686A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017326013B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019005040A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3036984C (cg-RX-API-DMAC7.html) |
| DK (2) | DK4005570T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2909557T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE058314T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL265342B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX388845B (cg-RX-API-DMAC7.html) |
| PL (2) | PL3512506T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018053280A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA122999C2 (uk) | 2013-06-21 | 2021-02-03 | Прайлінія Н'Юротерапьютікс Лтд. | Застосування придопідину для лікування хвороби гантінгтона |
| US11090297B2 (en) | 2013-06-21 | 2021-08-17 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating huntington's disease |
| EP3503890B1 (en) | 2016-08-24 | 2024-12-18 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine for treating dystonias |
| MX390627B (es) | 2016-08-24 | 2025-03-21 | Prilenia Neurotherapeutics Ltd | Uso de pridopidina para el tratamiento de la disminucion funcional. |
| US12102627B2 (en) | 2016-09-16 | 2024-10-01 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine for treating rett syndrome |
| CN109982686A (zh) | 2016-09-16 | 2019-07-05 | 普瑞尼亚医疗发展有限公司 | 普利多匹定用于治疗rett综合征的用途 |
| US12036213B2 (en) | 2017-09-08 | 2024-07-16 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating drug induced dyskinesias |
| BR112021015346A2 (pt) | 2019-02-04 | 2021-10-05 | Prilenia Neurotherapeutics Ltd. | Uso de pridopidina de baixa dose para a doença de parkinson e outras doenças associadas ao parkinsonismo |
| CN116472043A (zh) * | 2020-10-20 | 2023-07-21 | 普瑞尼亚神经治疗有限公司 | 普利多匹定和类似物用于治疗焦虑和抑郁的用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904724D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
| CA2584831C (en) | 2004-10-13 | 2013-09-17 | Neurosearch Sweden Ab | Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
| JP2013536825A (ja) | 2010-09-03 | 2013-09-26 | イバックス・インターナショナル・ゲーエムベーハー | ドパミン作動性安定化剤として有用なプリドピジンの重水素化類似体 |
| WO2013086425A1 (en) * | 2011-12-08 | 2013-06-13 | IVAX International GmbH | The hydrobromide salt of pridopidine |
| US20130267552A1 (en) | 2012-04-04 | 2013-10-10 | IVAX International GmbH | Pharmaceutical compositions for combination therapy |
| UA122999C2 (uk) | 2013-06-21 | 2021-02-03 | Прайлінія Н'Юротерапьютікс Лтд. | Застосування придопідину для лікування хвороби гантінгтона |
| JP6949487B2 (ja) * | 2014-01-22 | 2021-10-13 | プリレニア・ニューロセラピューティクス・エルティーディーＰｒｉｌｅｎｉａ Ｎｅｕｒｏｔｈｅｒａｐｅｕｔｉｃｓ Ｌｔｄ | プリドピジンの調節放出製剤 |
| EP4282479A3 (en) * | 2015-02-25 | 2024-02-21 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to treat depression or anxiety |
| WO2016138135A1 (en) * | 2015-02-25 | 2016-09-01 | Teva Pharmaceuticals International Gmbh | Sigma-1 receptor modulators for treating huntington's disease |
| CN109982686A (zh) | 2016-09-16 | 2019-07-05 | 普瑞尼亚医疗发展有限公司 | 普利多匹定用于治疗rett综合征的用途 |
-
2017
- 2017-09-15 CN CN201780071045.XA patent/CN109982686A/zh active Pending
- 2017-09-15 DK DK22150695.9T patent/DK4005570T3/da active
- 2017-09-15 CA CA3036984A patent/CA3036984C/en active Active
- 2017-09-15 DK DK17851614.2T patent/DK3512506T3/da active
- 2017-09-15 AU AU2017326013A patent/AU2017326013B2/en active Active
- 2017-09-15 ES ES17851614T patent/ES2909557T3/es active Active
- 2017-09-15 JP JP2019514217A patent/JP6977029B2/ja active Active
- 2017-09-15 HU HUE17851614A patent/HUE058314T2/hu unknown
- 2017-09-15 EP EP17851614.2A patent/EP3512506B1/en active Active
- 2017-09-15 MX MX2019003069A patent/MX388845B/es unknown
- 2017-09-15 WO PCT/US2017/051803 patent/WO2018053280A1/en not_active Ceased
- 2017-09-15 BR BR112019005040A patent/BR112019005040A2/pt not_active Application Discontinuation
- 2017-09-15 PL PL17851614T patent/PL3512506T3/pl unknown
- 2017-09-15 PL PL22150695.9T patent/PL4005570T3/pl unknown
- 2017-09-15 ES ES22150695T patent/ES2986807T3/es active Active
- 2017-09-15 EP EP22150695.9A patent/EP4005570B1/en active Active
-
2019
- 2019-03-13 IL IL265342A patent/IL265342B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN109982686A (zh) | 2019-07-05 |
| JP2019532926A (ja) | 2019-11-14 |
| MX388845B (es) | 2025-03-20 |
| ES2986807T3 (es) | 2024-11-12 |
| PL4005570T3 (pl) | 2024-09-23 |
| IL265342A (en) | 2019-05-30 |
| AU2017326013B2 (en) | 2020-12-24 |
| DK3512506T3 (da) | 2022-04-19 |
| DK4005570T3 (da) | 2024-08-19 |
| AU2017326013A1 (en) | 2019-04-11 |
| EP3512506A1 (en) | 2019-07-24 |
| EP4005570A1 (en) | 2022-06-01 |
| MX2019003069A (es) | 2019-09-02 |
| CA3036984C (en) | 2023-07-18 |
| HUE058314T2 (hu) | 2022-07-28 |
| PL3512506T3 (pl) | 2022-05-30 |
| JP6977029B2 (ja) | 2021-12-08 |
| IL265342B2 (en) | 2023-06-01 |
| WO2018053280A1 (en) | 2018-03-22 |
| CA3036984A1 (en) | 2018-03-22 |
| EP3512506A4 (en) | 2020-05-27 |
| EP4005570B1 (en) | 2024-05-15 |
| EP3512506B1 (en) | 2022-01-26 |
| BR112019005040A2 (pt) | 2019-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2909557T3 (es) | Utilización de la pridopidina para el tratamiento del síndrome de Rett | |
| CN102065897B (zh) | 基于磺胺异噁唑的组合物用于制备治疗阿茨海默病的药物的应用 | |
| US20190247333A1 (en) | Method of reduction in convulsive seizure frequency | |
| JP2020535228A (ja) | 患者集団中のけいれん発作の数および頻度の低減におけるフェンフルラミン製剤の使用法 | |
| JP2012528818A (ja) | Ｃｍｔ及び関連障害を処置するための新たな組成物 | |
| AU2018383098B2 (en) | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions | |
| US20160193231A1 (en) | Rett syndrome and treatments therefore | |
| US10113171B2 (en) | Methods for improving cognitive function via modulation of quinone reductase 2 | |
| US20210393591A1 (en) | Treatments for charcot-marie-tooth disease | |
| US20240398778A1 (en) | Use of pridopidine for treating rett syndrome | |
| US20230414596A1 (en) | Use of pridopidine and analogs for treating rett syndrome | |
| CN108601772A (zh) | 用于治疗tdp-43蛋白质病的他克莫司 | |
| AU2021383325B2 (en) | Use of pridopidine and analogs for treating rett syndrome | |
| HK40009961B (en) | Use of pridopidine for treating rett syndrome | |
| RU2799049C2 (ru) | Способы лечения изменений поведения | |
| de Brito | Pharmacological modulation of mutant ataxin-3 translation and it potential therapeutic effect in Machado Joseph disease | |
| TW201929850A (zh) | 醫藥組成物於製備預防或治療不正常乙型-澱粉樣蛋白聚集類疾病之藥物上之用途 | |
| GB2558788A (en) | New therapeutic uses |